IGT Comments on CMS Fiscal Year 2023 Medicare Inpatient Prospective Payment Systems Proposed Rule
Earlier this month the Institute for Gene Therapies submitted a comment letter to the Centers for Medicare and Medicaid Services (CMS) on...
IGT Comments on CMS Fiscal Year 2023 Medicare Inpatient Prospective Payment Systems Proposed Rule
New Resource: Understanding the Complexity of Gene Therapy Science & Manufacturing
IGT Chairman Erik Paulsen Joins Healthy Future Task Force Treatments Subcommittee Roundtable
A Troubling Policy Proposal
Prioritizing Minority Health
IGT Statement on the Introduction of the Medicaid VBPs for Patients Act (H.R. 7389)
Rare Disease Day Spotlight: Hope for HPP Patients
Changing the Way We Look at Huntington’s Disease
IGT Statement on CMS Final Rule on Medicaid Value-based Purchasing Arrangements
IGT Statement on Senate's FY2022 Appropriations Bill